Additional file 1 of Infographics on risks associated with COVID-19 and the willingness to get the AstraZeneca vaccine: two randomized online experiments

Additional file 1. Supplementary information and analyses

sj-pdf-3-hpq-10.1177_13591053221149526 – Supplemental material for Promoting prosociality toward future generations in antibiotic intake

Supplemental material, sj-pdf-3-hpq-10.1177_13591053221149526 for Promoting prosociality toward future generations in antibiotic intake by Ana Paula Santana, Lars Korn, Cornelia Betsch and Robert Böhm in Journal of Health Psychology</p

sj-rmd-2-hpq-10.1177_13591053221149526 – for Promoting prosociality toward future generations in antibiotic intake

sj-rmd-2-hpq-10.1177_13591053221149526 for Promoting prosociality toward future generations in antibiotic intake by Ana Paula Santana, Lars Korn, Cornelia Betsch and Robert Böhm in Journal of Health Psychology</p

sj-docx-1-hpq-10.1177_13591053221149526 – for Promoting prosociality toward future generations in antibiotic intake

sj-docx-1-hpq-10.1177_13591053221149526 for Promoting prosociality toward future generations in antibiotic intake by Ana Paula Santana, Lars Korn, Cornelia Betsch and Robert Böhm in Journal of Health Psychology</p

Additional file 1 of Exploring pre-pandemic patterns of vaccine decision-making with the 5C model: results from representative surveys in 2016 and 2018

Supplementary Material 1: Sample Demographics

Exclusion criteria used in selection process for literature review on influenza vaccine hesitancy.

<p>Exclusion criteria used in selection process for literature review on influenza vaccine hesitancy.</p

Micro-level determinants of vaccine hesitancy following an extended version of the Theory of Planned Behavior (TPB).

<p>Determinants are based on empirical and theoretical work from Ajzen [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0170550#pone.0170550.ref023" target="_blank">23</a>], Schmiege et al. [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0170550#pone.0170550.ref025" target="_blank">25</a>], Rhodes & Courneya [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0170550#pone.0170550.ref026" target="_blank">26</a>], Koo et al. [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0170550#pone.0170550.ref027" target="_blank">27</a>], Pomery et al. [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0170550#pone.0170550.ref028" target="_blank">28</a>], Larson et al. [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0170550#pone.0170550.ref010" target="_blank">10</a>]. Significant determinants from 470 research articles are clustered according to the model. Circle size represents the total number of reported incidents.</p

Barriers to influenza vaccine uptake mapped onto the macro-level 4C model of vaccine hesitancy (complacency, convenience, confidence and calculation).

<p>Total numbers of studies reporting the variable as either decreasing (white) or increasing (black) vaccine acceptance or inconclusive (circled number).</p

Keywords used for the literature search.

<p>Keywords used for the literature search.</p

Flow Chart of selection process.

<p>Flow Chart of selection process.</p